Survival Curve from Scientific Research

Stage III (n = 1,052). Patients were stratified by the receipt of adjuvant chemotherapy. Statistical interaction tests were performed for the following: (left panel) predicted DLRS low vs. high and adjuvant chemotherapy: pinteraction= 0.001 and 0.011 for stage II and stage III; (right panel) predicted DLRS low vs. high and adjuvant chemotherapy: pinteraction= 0.001 and 0.006 for stage II and stage III.

DOI